Clinical Research Directory
Browse clinical research sites, groups, and studies.
Myo-Inositol for Infertility in PCOS
Sponsor: University of Oklahoma
Summary
This will be a prospective, double-blind randomized clinical trial of letrozole and placebo versus letrozole and inositols for up to 5 treatment cycles of ovulation induction or until pregnancy is achieved. All participants and members of the research team will be blinded to the treatment arms. Placebo and inositol supplement will be packaged to appear the same, tested, and packaged by a commercial supply company. The inositols will be a 40:1 blend of myo-inositol and D-chiro inositol.
Official title: Myo-Inositol as an Adjuvant to Letrozole for Infertility in PolyCystic Ovary Syndrome (MALI-PCOS): a Randomized Pilot Trial
Key Details
Gender
All
Age Range
18 Years - 36 Years
Study Type
INTERVENTIONAL
Enrollment
168
Start Date
2022-02-07
Completion Date
2026-12
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Inositol supplement
Inositol supplements given to inositol arm
Placebo supplement
Placebo supplement given to placebo arm
Locations (1)
OUHSC Reproductive Medicine Clinic
Oklahoma City, Oklahoma, United States